Delivery Order SPE2DR25D1205-SPE2DR26F1AP7
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,679.64 on January 6, 2026, for FreeStyle Libre 3 Plus Sensors. This firm fixed-price contract, with an ultimate completion date of January 7, 2026, was competitively awarded without set-aside restrictions through the Defense Logistics Agency (DLA), which funds military and federal healthcare supply chains. The delivery order represents a task...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,584.76 for Freestyle Libre 3 Plus Sensors on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors valued at $31,084.20. This competitively awarded, firm fixed-price delivery order is set to be completed by September 11, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency awarded a $2,234.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for Freestyle Libre 3 Plus sensors, with completion scheduled for December 10, 2025. This is an unclassified, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor serving military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $11,778.21 on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,298.15 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on July 29, 2025, with completion expected by July 30, 2025. This firm fixed price delivery order represents a continuation of the company's extensive pharmaceutical and medical supply support to federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Freestyle Libre 3 Plus Sensors valued at $31,779.55. This is a firm fixed-price, non-set-aside contract with a completion date of July 24, 2025, and performance to be executed in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus sensors on September 24, 2025, with completion expected by September 25, 2025. This non-competitive, firm fixed-price delivery order represents a small-value medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively procured delivery order by the Defense Logistics Agency (DLA) on January 2, 2026, for Freestyle Libre 3 Plus Sensors with a ceiling value of $5,150.40 and an ultimate completion date of January 5, 2026. The contract employs firm fixed price terms and carries no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $10,945.34 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AP7Delivery Order
On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $11,614.15 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors. This non-competitive delivery order, with a firm fixed-price structure and an ultimate completion date of January 26, 2026, represents a small but critical medical supply requirement for the military healthcare system. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the overarching vehicle for pharmaceutical and medical supply procurement to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The Freestyle Libre 3 Plus Sensors—continuous glucose monitoring devices used in diabetes management—represent the type of specialized medical commodity routinely supplied under the parent IDC agreement. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical devices across multiple therapeutic domains, all structured as firm fixed-price arrangements with the Defense Logistics Agency. The company competes on a full and open basis for federal contracts, with no set-aside designations applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 1/22/26 |